Replacing manual sphygmomanometers with automated blood pressure measurement in routine clinical practice

Clinical and Experimental Pharmacology and Physiology

Volumn 41, Issue 1, 2014, Pages 46-53

  Myers, Martin G ^a,b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Automated blood pressure measurement; Hypertension diagnosis; White coat hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE THERAPY; ARTERIAL WALL THICKNESS; ARTICLE; AUTOMATION; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE METER; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; CAROTID ARTERY; CLASSIFICATION ALGORITHM; CLINICAL PRACTICE; CONSENSUS; DIAGNOSTIC ACCURACY; HEART AUSCULTATION; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; MERCURY SPHYGMOMANOMETER; MICROALBUMINURIA; OBSERVER BIAS; PRACTICE GUIDELINE; SPHYGMOMANOMETER; TARGET ORGAN; WHITE COAT HYPERTENSION;

AUTOMATED BLOOD PRESSURE MEASUREMENT; HYPERTENSION DIAGNOSIS; WHITE COAT HYPERTENSION;

ALGORITHMS; AUTOMATION; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; BLOOD PRESSURE MONITORING, AMBULATORY; HUMANS; HYPERTENSION; PHYSICIANS' OFFICES; SPHYGMOMANOMETERS; WHITE COAT HYPERTENSION;

EID: 84891468428     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/1440-1681.12149     Document Type: Article

References (52)

1. Myers MG, Oh P, Reeves RA, Joyner CD. Prevalence of white coat effect in treated hypertensive patients in the community. Am. J. Hypertens. 1995; 8: 591-7.
2. Myers MG, Godwin M, Dawes M, Kiss A, Tobe SW, Kaczorowski J. Measurement of blood pressure in the office: Recognizing the problem and proposing the solution. Hypertension 2010; 55: 195-200.
3. Hansen TW, Kikuya M, Lutgarde T et al. Prognostic superiority of daytime ambulatory over conventional blood pressure in four populations: A meta-analysis of 7030 individuals. J. Hypertens. 2007; 25: 1554-64.
4. Ward AM, Takahashi O, Stevens R, Heneghan C. Home measurement of blood pressure and cardiovascular disease. Systematic review and meta-analysis of prospective studies. J. Hypertens. 2012; 30: 449-56.
5. Myers MG, Tobe SW, McKay DW, Bolli P, Hemmelgarn BR, McAlister FA. New algorithm for the diagnosis of hypertension. Canadian Hypertension Education Program recommendations (2005). Am. J. Hypertens. 2005; 18: 1369-74.
6. National Institute for Health and Clinical Excellence. Hypertension NICE Clinical Guidelines 127. National Clinical Guidelines Centre, London, 2011.
7. Head GA, McGrath BP, Mihailidou AS et al. Ambulatory blood pressure monitoring n Australia: 2011 consensus position statement. J. Hypertens. 2012; 30: 253-66.
8. O'Brien E. Ambulatory blood pressure measurement: The case for implementation in primary care. Hypertension 2008; 51: 1435-41.
9. Zanchetti A, Mancia G. Longing for clinical excellence: A critical look into the NICE rccommendations on hypertension managemen: is nice always good? J. Hypertens. 2012; 30: 660-8.
10. Gustavsen PH, Hoegholm A, Bang LE, Kristensen KS. White coat hypertension is a cardiovascular risk factor: A 10-year follow-up study. J. Hum. Hypertens. 2003; 17: 811-7.
11. Scientific Committee on Emerging and Newly Identified Health Risks. Mercury Sphygmomanometers in Healthcare and the Feasibility of Alternatives. 2009. Available from: http://ec.europa.eu/health/ph_risk/committees/04_scenihr/scenihr_opinions_en.htm#2 (accessed 17 July 2013).
12. Graves JW, Tibor M, Murtagh B, Klein L, Sheps SG. The Accoson Greenlight 300, the first non-automated mercury-free blood pressure measurement device to pass international protocol for blood pressure measuring devices in adults. Blood Press. Monit. 2004; 9: 13-7.
13. Tasker F, de Greff A, Liu B, Shennan AH. Validation of a non-mercury ascultatory device according to the European Society of Hypertension protocol: Rosssmax Mandaus II. Blood Press. Monit. 2009; 14: 121-4.
14. Ishikawa J, Nasothimiou G, Karpettas N et al. Automatic blood pressure measured without doctors or nurses present. Blood Press. Monit. 2012; 17: 96-102.
15. Ogedegbe G, Pickering TG, Clemow L et al. The misdiagnosis of hypertension. Arch. Intern. Med. 2008; 168: 2459-65.
16. Le Pailleur C, Helft G, Landais P et al. The effects of talking, reading, and silence on the 'white coat' phenomenon in hypertensive patients. Am. J. Hypertens. 1998; 11: 203-20.
17. Nietert PJ, Wessell AM, Feifer C, Ornstein SM. Effect of terminal digit preference on blood pressure measurement and treatment in primary care. Am. J. Hypertens. 2006; 19: 147-52.
18. Eguchi K, Kuruvilla S, Ogedegbe G, Gerin W, Schwartz JE, Pickering TG. What is the optimal interval between successive home blood pressure readings using an automated oscillometric device? J. Hypertens. 2009; 27: 1172-7.
19. O'Brien E, Pickering T, Asmar R et al. Working Group on Blood Pressure Monitoring of the European Society of Hypertension International Protocol for validation of blood pressure measuring devices in adults. Blood Press. Monit. 2002; 7: 3-7.
20. Stergiou GS, Parati G. Should the measurement of blood pressure in the office be redefined? J. Hypertens. 2012; 30: 1906-8.
21. Beta) with the auscultatory mercury sphygmomanometer. Blood Press. Monit. 2001; 6: 153-9.
22. White WG, Anwar YA. Evaluation of the overall efficacy of the Omron office digital blood pressure HEM-907 monitor in adults. Blood Press. Monit. 2001; 6: 107-10.
23. Stergiou GS, Tzamouranis D, Protogerou A, Nasothimiou E, Kapralos C. Validation of the Microlife Watch BP Office Professional device for office blood pressure measurement according to the international protocol. Blood Press. Monit. 2008; 13: 299-303.
24. Graves JW, Nash C, Burger K, Bailey K, Sheps SG. Clinical decision-making in hypertension using an automated (BpTRU) measurement device. J. Hum. Hypertens. 2003; 17: 823-7.
25. Myers MG, Valdivieso MA. Use of an automated blood pressure recording device, the BpTRU, to reduce the 'white coat effect' in routine practice. Am. J. Hypertens. 2003; 16: 494-7.
26. Beckett L, Godwin M. The BpTRU automatic blood pressure monitor compared to 24-h ambulatory blood pressure monitoring in the assessment of blood pressure in patients with hypertension. BMC Cardiovasc. Disord. 2005; 5: 18.
27. Myers MG, Valdivieso M, Kiss A. Use of automated office blood pressure measurement to reduce the white coat response. J. Hypertens. 2009; 27: 280-6.
28. Niyonsenga T, Vanasse A, Couteau J, Cloutier L. Impact of terminal digit preference by family physicians and sphygmomanometer calibration errors on blood pressure value: Implication for hypertension screening. J. Clin. Hypertens. 2008; 10: 341-7.
29. Myers MG, Godwin M, Dawes M et al. Conventional versus automated measurement of blood pressure in primary care patients with systolic hypertension: Randomized parallel design controlled trial. BMJ 2011; 342: d286.
30. Sedgwick P. The Hawthorne effect. BMJ 2011; 344: d8262.
31. Gerin W, Marion RM, Friedman R, James GD, Bovbjerg DH, Pickering TG. How should we measure blood pressure in the doctor's office? Blood Press. Monit. 2001; 6: 257-62.
32. Hong D, Su H, Li J et al. The effect of physician presence on blood pressure. Blood Press. Monit. 2012; 17: 145-8.
33. Culleton BF, McKay DW, Campbell NR. Performance of the automated BpTRU measurement device in the assessment of white-coat hypertension and white-coat effect. Blood Press. Monit. 2006; 11: 37-42.
34. Myers MG, Valdivieso M, Kiss A. Optimum frequency of automated blood pressure measurements using an automated sphygmomanometer. Blood Press. Monit. 2008; 13: 333-8.
35. Myers MG, Valdivieso M, Kiss A. Consistent relationship between automated office blood pressure recorded in different settings. Blood Press. Monit. 2009; 14: 108-11.
36. Myers MG, Valdivieso M, Kiss A, Tobe SW. Comparison of two automated sphygmomanometers for use in the office setting. Blood Press. Monit. 2009; 14: 45-7.
37. Myers MG, Valdivieso M. Evaluation of an automated sphygmomanometer for use in the office setting. Blood Press. Monit. 2012; 17: 116-9.
38. Myers MG, Godwin M, Dawes M, Kiss A, Tobe SW, Kaczorowski J. The conventional versus automated measurement of blood pressure in the office (CAMBO) trial: Masked hypertension sub-study. J. Hypertens. 2012; 30: 1937-41.
39. Myers MG, Meglis G, Polemidiotis G. The impact of physician vs automated blood pressure readings on office-induced hypertension. J. Hum. Hypertens. 1997; 11: 491-3.
40. Myers MG, Valdivieso M, Chessman M, Kiss A. Can sphygmomanometers designed for self-measurement of blood pressure in the home be used in office practice? Blood Press. Monit. 2010; 15: 300-4.
41. Campbell NRC, McKay DW, Conradson H, Lonn E, Title LM, Anderson T. Automated oscillometric blood pressure versus auscultatory blood pressure as a predictor of carotid intima-media thickness in male fire-fighters. J. Hum. Hypertens. 2007; 21: 588-90.
42. Andreadis EA, Agaliotis GD, Angelopoulos ET, Tsakanikas AP, Chaveles IA, Mousoulis GP. Automated office blood pressure and 24-h ambulatory measurements are equally associated with left ventricular mass index. Am. J. Hypertens. 2011; 24: 661-6.
43. Andreadis EA, Agoliatis GD, Angelopoulos ET, Tsakanikas AP, Kolyvas GN, Mousoulis GP. Automated office blood pressure is associated with urine albumin excretion in hypertensive subjects. Am. J. Hypertens. 2012; 25: 969-73.
44. Kaczorowski J, Chambers LW, Karwalajtys T et al. Cardiovascular health awareness program (CHAP): A community cluster-randomised trial among elderly Canadians. Prevent. Med. 2008; 46: 537-44.
45. Pickering TG, Hall JE, Appel LJ et al. Recommendations for blood pressure measurement in humans and experimental animals part 1: Blood pressure measurement in humans a statement for professionals from the subcommittee of Professional and Public Education of the AM Heart Association Council on High Blood Pressure Research. Hypertension 2005; 45: 142-61.
46. Stergiou GS, Kollias A, Destounis A, Tzamouranis D. Automated blood pressure in atrial fibrillation: A systematic review and meta-analysis. J. Hypertens. 2012; 30: 2074-82.
47. Greiver M, White D, Kaplan DM, Katz K, Moineddin R, Doabchian E. Where should automated blood pressure measurements be taken? Blood Press. Monit. 2012; 17: 137-8.
48. Kikuya M, Hansen T, Lutgarde T et al. Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk. Circulation 2007; 115: 2145-52.
49. Niiranen TJ, Asayama K, Thijs L et al. Outcome-driven thresholds for home blood pressure measurement. Hypertension 2012; 61: 27-34.
50. Myers MG. The great myth of office blood pressure measurement. J. Hypertens. 2012; 30: 1894-8.
51. Myers MG. A proposed algorithm for diagnosing hypertension using automated office blood pressure measurement. J. Hypertens. 2010; 28: 703-8.
52. Godwin M, Birtwhistle R, Delva D et al. Manual and automated office measurements in relation to awake ambulatory blood pressure monitoring. Fam. Pract. 2011; 28: 110-7.